MT-II is a cyclic heptapeptide broadly activating MC1R, MC3R, and MC4R , simultaneously producing melanogenesis alongside central pro-sexual, pro-erectile, and anorectic effects through hypothalamic MC3R/MC4R activation, Cyclisation of the -MSH pharmacophore core is the primary structural determinant of this receptor subtype selectivity shift
'Purchasing drugs from illegal sources is like playing the lottery with your life
Importantly, in terms of serious adverse events there was one in the placebo arm (cholecystitis) and two in liraglutide arm (left upper quadrant pain and abdominal pain)
Risk factors include the speed and magnitude of weight loss, pre-existing nutritional deficiencies, age, sex (women are more commonly affected), and individual genetic susceptibility
Gorter, Riccardo M